Serum Magnesium, Insulin Resistance, and Cardiovascular Risk Markers in  Metabolic Syndrome

Rafia Abbas, Muhammad Own Ali, Tashfeen Ikram, Sidra Zahid, Imran Ali, Shazia Hameed, Sadia Yousaf

Serum Magnesium, Insulin Resistance, and Cardiovascular Risk Markers in Metabolic Syndrome

Authors

Rafia Abbas, Muhammad Own Ali, Tashfeen Ikram, Sidra Zahid, Imran Ali, Shazia Hameed, Sadia Yousaf

Keywords:

Metabolic syndrome;Magnesium; Insulin resistance

Abstract

Metabolic syndrome is a multifactorialmetabolic disorder characterized by centralobesity, insulin resistance, dyslipidemia,hypertension, and increased cardiovascular risk. Emerging evidence suggests that serummagnesium plays a significant role in glucosemetabolism, insulin sensitivity,

References

1. Saklayen MG. The global epidemic of metabolic syndrome. Curr Hypertens Rep. 2022;24(3):45-56. DOI: https://doi.org/10.1007/s11906-022-01167-8

2. Grundy SM. Metabolic syndrome update: pathophysiology and clinical implications. Circulation. 2023;147(8):635-648. DOI:

https://doi.org/10.1161/CIRCULATIONAH A.122.061829

Downloads

Published

2026-08-11

How to Cite

Rafia Abbas, Muhammad Own Ali, Tashfeen Ikram, Sidra Zahid, Imran Ali, Shazia Hameed, Sadia Yousaf. (2026). Serum Magnesium, Insulin Resistance, and Cardiovascular Risk Markers in Metabolic Syndrome . International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 2445–2455. Retrieved from https://ijprt.org/index.php/pub/article/view/2710